EUVIMEDEUVIMED entdecken
Open Access

Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry

Arun Krishnaraj iD, Sreejith J Nair iD

Current Protocols · 2024

DOI: 10.1002/cpz1.70012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Arun Krishnaraj und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservior Rd NW, Washington, District of Columbia, USA, 200…. Hauptthemen laut MEDLINE: Cisplatin, Mass Spectrometry, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Department of Defense, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The platinum‐based anticancer drug cisplatin and its analog carboplatin are the most used chemotherapeutic agents worldwide. It is estimated that approximately half of all cancer patients are treated with platinum drugs at some point during the therapy regimen. Cisplatin covalently binds to purine nucleobases to form DNA adducts. Cisplatin therapy is faced with two key challenges. First, despite the initial response, many patients develop cisplatin resistance. Reduced cellular accumulation of cisplatin is one common cause of therapy resistance. Second, cisplatin treatment causes general cytotoxicity, leading to severe side effects. Monitoring the subcellular concentration of platinum chemotherapeutics will help yield clinical efficacy with the minimum possible dose. Inductively coupled plasma‐mass spectrometry (ICP‐MS) is an analytical technique to quantify the elemental composition of various types of liquified bulk samples with high sensitivity. This article describes quantifying cisplatin accumulation in chromatin and total cell lysate using ICP‐MS. The method involves treating cells with cisplatin, isolating RNA‐free DNA, digesting samples, ICP‐MS instrumentation, and data analysis. Although we describe these steps in one cancer cell line, the protocol can be adapted to any cell line or tissue. The protocol should be a valuable resource for investigators interested in accurate measurement of subcellular concentration of platinum and other metallo‐drugs. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Cell culture conditions for A2780 cells and cisplatin treatment Basic Protocol 2 : Isolating cellular fractions and sample quantitation Basic Protocol 3 : Sample digestion, ICP‐MS data collection, and analysis

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinMass SpectrometryAntineoplastic AgentsHumansPlatinumCell Line, TumorChromatin

Stichwörter der Autor:innen

ICP‐MSchemoresistancechemotherapycisplatinmass spectrometrymetallodrugsnucleic acid

Substanzen

CisplatinAntineoplastic AgentsPlatinumChromatin

Autor:innen und Institutionen

  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservior Rd NW, Washington, District of Columbia, USA, 20057.

ORCID-Profile: Arun Krishnaraj, Sreejith J Nair

Förderung

  • NIH HHS
  • Department of Defense
  • National Institutes of Health
  • U.S. Department of Defense

Zitieren

APA

Krishnaraj, A., & Nair, S. J. (2024). Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry. Current Protocols. https://doi.org/10.1002/cpz1.70012

Vancouver

Krishnaraj A, Nair SJ. Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry. Current Protocols. 2024. doi:10.1002/cpz1.70012

BibTeX
@article{Krishnaraj2024,
  author = {Krishnaraj, Arun and Nair, Sreejith J},
  title = {Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry},
  journal = {Current Protocols},
  year = {2024},
  doi = {10.1002/cpz1.70012}
}
Kostenlos starten →